Saku App
Saku Terminal • $NVOLive $NVO AI Target, Catalysts & Support Levels
OPEN
Saku Logo
Saku
Back to Saku Market Terminal
Climate: BULLISH FLOW
Updated Nov 15, 2026
Saku AI Market Briefing • $NVO (Novo Nordisk)

$NVO (Novo Nordisk) Support & Resistance Levels, AI Price Target & Institutional Flow.

$NVO (Novo Nordisk) live technical levels: 30D Support Floor at $37.53, 20D SMA Pivot at $39.97, and 30D Resistance Ceiling at $42.18 (14D RSI: 61.7 • BULLISH MOMENTUM (61.7)) — plus live dark pool whale flow, bull/bear thesis, and locked 1-month AI price target.

Saku AI Synthesis • Why Is $NVO Moving?
30D Support$37.53
30D Resistance$42.18
20-Day SMA$39.97
14-Day RSI61.7

Spot Price: $41.63 | 30-Day Support Floor: $37.53 (9.85% above) | 10-Day EMA: $40.92 | 20-Day SMA Pivot: $39.97 | 30-Day Resistance Ceiling: $42.18 (1.32% below) | 14-Day RSI: 61.7 (BULLISH MOMENTUM (61.7)) | 30-Day Trading Corridor: 12.39% span. Novo Nordisk ($NVO) is currently trading at $41.63—holding above its 20-day simple moving average ($39.97) and 10-day exponential moving average ($40.92) with a 5-day price velocity of +3.27% and 14-day RSI at 61.7 (BULLISH MOMENTUM (61.7)). With a live market capitalization of $184.66B and a trailing P/E multiple of 11.03x, bullish continuation targets a high-volume test of the 30-day resistance ceiling and options Call Wall at $42.18 (1.32% below spot).

LIVE TERMINAL TELEMETRY
$41.63+2.41%
BULLISH FLOW
$NVO 30-DAY PRICE ACTION • BULLISH FLOWUpdated Nov 15, 2026
$NVO Momentum Pulse (1–100)68/100
Fundamental Health Score74/100
Assign Ronin to Guard $NVO 24/7
3x/Day Shift Briefs & 24/7 Stop-Loss Sentinel
+ GUARD
Locked 1-Month AI Target:$47.54 (+14.2%)Unlock Free →
Open Interactive $NVO Chart & Ask @Saku
Institutional Quantitative & Fundamental Telemetry

$NVO (Novo Nordisk) Live Key Levels, RSI & Valuation Matrix

Updated Nov 15, 2026
$NVO Technical MetricLive Value$NVO Fundamental / Regime MetricLive Status
Live Spot Price (24h Change)$41.63 (+2.41%)Market Capitalization$184.66B
30-Day Mechanical Support Floor (Put Wall)$37.53 (9.85% cushion)52-Week High / Low Range$35.12 – $64.16
20-Day Simple Moving Average (20D SMA)$39.97Trailing P/E Ratio & Dividend Yield11.03x • Yield: 4.32%
10-Day Exponential Moving Average (10D EMA)$40.92Average Daily Volume (Liquidity)16.57M shares
30-Day Resistance Ceiling (Call Wall)$42.18 (1.32% upside to test)Next Scheduled Earnings / Catalyst Window2027-02-03
14-Day Relative Strength Index (RSI)BULLISH MOMENTUM (61.7)Saku Momentum Pulse & Health Rating68/100 Momentum • 74/100 Health
Want live sub-second candlesticks, 20D SMA / 50D EMA overlays, and real-time Support & Resistance alerts on $NVO?Launch Interactive $NVO Chart
Saku AI Bull vs. Bear Breakdown

Should You Buy $NVO Stock Now or Wait?

$NVO Bull CaseUPSIDE DRIVERS

Novo Nordisk ($NVO) is currently trading at $41.63—holding above its 20-day simple moving average ($39.97) and 10-day exponential moving average ($40.92) with a 5-day price velocity of +3.27% and 14-day RSI at 61.7 (BULLISH MOMENTUM (61.7)). With a live market capitalization of $184.66B and a trailing P/E multiple of 11.03x, bullish continuation targets a high-volume test of the 30-day resistance ceiling and options Call Wall at $42.18 (1.32% below spot).

Momentum Pulse: 68/100 (BULLISH FLOW)Predict Bull Target
$NVO Bear Case & RisksRISK FACTORS

Primary downside invalidation for $NVO (Novo Nordisk) centers on a failure to clear the $42.18 30-day resistance ceiling followed by a daily close below the 20-day moving average pivot at $39.97. Losing $39.97 on elevated volume opens a mechanical retest of the $37.53 Put Wall support zone inside a 52-week structural corridor of $35.12 to $64.16.

Fundamental Health: 74/100 ScoreAudit Downside Risk
Technicals, Volume & Catalysts

$NVO Support & Resistance, Institutional Flow & Catalysts.

Key Price Zones

$NVO Support & Resistance

Spot Price: $41.63 | 30-Day Support Floor: $37.53 (9.85% above) | 10-Day EMA: $40.92 | 20-Day SMA Pivot: $39.97 | 30-Day Resistance Ceiling: $42.18 (1.32% below) | 14-Day RSI: 61.7 (BULLISH MOMENTUM (61.7)) | 30-Day Trading Corridor: 12.39% span.

Chart IndicatorsSMA • EMA • RSI
Volume & Options Activity

$NVO Institutional & Whale Flow

Institutional order flow for $NVO (averaging 16.57M shares daily volume) is concentrated between the $37.53 Put Wall support zone and $42.18 Call Wall resistance ceiling, with a live Saku Fundamental Health score of 74/100.

Saku Pro Deep-DiveTRACKED
Upcoming Events

$NVO Catalyst Outlook

Next scheduled earnings window for Novo Nordisk ($NVO): 2027-02-03. Latest tracked headline from simplywall.st: "Ascendis Pharma (ASND) Stock Looks Reasonable Following Its 22% Run".

Asset & Corporate Profile

About Novo Nordisk ($NVO)

Novo Nordisk is a leading global health care company that's been making innovative medicines to help people with diabetes lead longer, healthier lives for more than 100 years. This heritage has given us experience and capabilities that also enable us to drive change to help people defeat other serious chronic diseases such as obesity, rare blood, and endocrine disorders. We remain steadfast in our conviction that the formula for lasting success is to stay focused, think long-term, and do business in a financially, socially, and environmentally responsible way.

Saku's quantitative engine continuously monitors $NVO's 30-day mechanical support floor ($37.53), 20-day simple moving average ($39.97), and 30-day resistance ceiling ($42.18) alongside off-exchange dark pool block prints and SEC filings.

Market Cap$184.66B
5-Day Velocity+3.27%
52-Week Range$35.12 – $64.16
Avg Daily Vol16.57M shares
Inspect Full $NVO Fundamentals in Terminal
3D Agent Sanctuary • Workstation #4🔥 Early Adopter Lock-In (First 500 Desks)🎁 Code LINKEDIN: 30 Days Pro Free

Hatch Your Own 24/7 AI Co-Pilot to Guard $NVO.

Step inside the 3D Quant Sanctuary and claim Workstation #4 to hatch your personal AI analyst (Momentum, Dip-Buyer, or Value & Catalyst style). Your agent monitors $NVO 24/7 with locked 1-month price targets, hard stop-loss tripwires, 3x/day shift briefings, and live Koi Bridge debates.

Unlock all 4 Autonomous Quant Agents & 24/7 Stop-Loss Guard:$29/mo$14.99/mo(or $8.33/mo annual • Early Adopter Rate + 30 Days Free w/ code LINKEDIN)
app.sakustocks.com • Live $NVO Terminal & Agent Sanctuary
Launch Full Terminal
Saku Institutional AI Terminal analyzing $NVO (Novo Nordisk)
“Ask @Saku or Ronin: Would you buy $NVO right now or wait for a pullback?”
5 Guard Slots • 50 Daily @Saku Queries
Frequently Asked Questions About $NVO

What are the live 30-day support and resistance levels for $NVO (Novo Nordisk)?

Spot Price: $41.63 | 30-Day Support Floor: $37.53 (9.85% above) | 10-Day EMA: $40.92 | 20-Day SMA Pivot: $39.97 | 30-Day Resistance Ceiling: $42.18 (1.32% below) | 14-Day RSI: 61.7 (BULLISH MOMENTUM (61.7)) | 30-Day Trading Corridor: 12.39% span. $NVO currently registers a Saku Momentum Pulse score of 68/100 and a Fundamental Health score of 74/100.

Why is $NVO (Novo Nordisk) moving and what is the bull vs. bear thesis?

Bull Thesis: Novo Nordisk ($NVO) is currently trading at $41.63—holding above its 20-day simple moving average ($39.97) and 10-day exponential moving average ($40.92) with a 5-day price velocity of +3.27% and 14-day RSI at 61.7 (BULLISH MOMENTUM (61.7)). With a live market capitalization of $184.66B and a trailing P/E multiple of 11.03x, bullish continuation targets a high-volume test of the 30-day resistance ceiling and options Call Wall at $42.18 (1.32% below spot). Bear Thesis: Primary downside invalidation for $NVO (Novo Nordisk) centers on a failure to clear the $42.18 30-day resistance ceiling followed by a daily close below the 20-day moving average pivot at $39.97. Losing $39.97 on elevated volume opens a mechanical retest of the $37.53 Put Wall support zone inside a 52-week structural corridor of $35.12 to $64.16.

What are $NVO's key fundamentals, 52-week range, and upcoming catalysts?

Novo Nordisk ($NVO) trades with a market cap of $184.66B, a P/E ratio of 11.03x, and a 52-week range of $35.12 to $64.16. Next scheduled earnings window for Novo Nordisk ($NVO): 2027-02-03. Latest tracked headline from simplywall.st: "Ascendis Pharma (ASND) Stock Looks Reasonable Following Its 22% Run".

Saku Tracked Assets

Explore More AI Stock & Crypto Quant Dossiers

View 14-Day Catalyst Calendar →

© 2026 Saku Financial Inc. Saku™ is a trademark of Saku Financial Inc.